drugset / Trial / NCT05100472
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find out whether combining a shorter than standard course of ADT with standard prostate brachytherapy and hypofractionated external beam radiation therapy is a safe and effective way to prevent high-risk prostate cancer from coming back and/or spreading to other parts of the body.
Timeline
- Start
- 2021-10-19
- Primary completion
- 2026-10-19
- Completion
- 2026-10-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bicalutamide | Other / unclassified | 50 mg | Oral |
| Subject | Leuprolide | Other / unclassified | 22.5 mg | Intramuscular |